Ipsen, represented by Dr. Sandra Silvestri, M.D., Ph.D
Sandra SILVESTRI, M.D., Ph.D., joined Ipsen in 2023 as Executive Vice President, Chief Medical Officer, Head of Global Medical Affairs and Pharmacovigilance. Prior to joining Ipsen, Dr. SILVESTRI held several senior positions at Sanofi, most recently as Senior Vice President, Chief Medical Officer of the Global General Medicine business unit, leading a team of 1,600 medical staff in various countries. She also held several management positions at Eli Lilly in various therapeutic areas, including diabetes, endocrinology, neuroscience, immunology, dermatology, and oncology. Sandra SILVESTRI is a physician specializing in endocrinology and metabolic diseases. As an investigator in several clinical studies, she has published numerous book chapters and scientific articles in international journals. Sandra SILVESTRI has been a speaker at national and international conferences and, from 2017 to 2023, she chaired Sanofi's Gender Balance Board and Global Network. She teaches at the medical schools of the University of Florence, Italy, and Descartes University in Paris. Sandra SILVESTRI has lived in Italy, Denmark, the United States, and France, and speaks Italian, English, and French.